Estimating incidence rates of periprosthetic joint infection after hip and knee arthroplasty for osteoarthritis using linked registry and administrative health data.

Arthroplasty Australian Orthopaedic Association National Joint Replacement Registry (AOANJRR) Infection Osteoarthritis arthroplasty registries hip and knee arthroplasty infections osteoarthritis (OA) periprosthetic joint infection (PJI) revision arthroplasties total knee and total hip arthroplasty

Journal

The bone & joint journal
ISSN: 2049-4408
Titre abrégé: Bone Joint J
Pays: England
ID NLM: 101599229

Informations de publication

Date de publication:
Sep 2022
Historique:
entrez: 1 9 2022
pubmed: 2 9 2022
medline: 9 9 2022
Statut: ppublish

Résumé

The aim of this study was to estimate the 90-day periprosthetic joint infection (PJI) rates following total knee arthroplasty (TKA) and total hip arthroplasty (THA) for osteoarthritis (OA). This was a data linkage study using the New South Wales (NSW) Admitted Patient Data Collection (APDC) and the Australian Orthopaedic Association National Joint Replacement Registry (AOANJRR), which collect data from all public and private hospitals in NSW, Australia. Patients who underwent a TKA or THA for OA between 1 January 2002 and 31 December 2017 were included. The main outcome measures were 90-day incidence rates of hospital readmission for: revision arthroplasty for PJI as recorded in the AOANJRR; conservative definition of PJI, defined by T84.5, the PJI diagnosis code in the APDC; and extended definition of PJI, defined by the presence of either T84.5, or combinations of diagnosis and procedure code groups derived from recursive binary partitioning in the APDC. The mean 90-day revision rate for infection was 0.1% (0.1% to 0.2%) for TKA and 0.3% (0.1% to 0.5%) for THA. The mean 90-day PJI rates defined by T84.5 were 1.3% (1.1% to 1.7%) for TKA and 1.1% (0.8% to 1.3%) for THA. The mean 90-day PJI rates using the extended definition were 1.9% (1.5% to 2.2%) and 1.5% (1.3% to 1.7%) following TKA and THA, respectively. When reporting the revision arthroplasty for infection, the AOANJRR substantially underestimates the rate of PJI at 90 days. Using combinations of infection codes and PJI-related surgical procedure codes in linked hospital administrative databases could be an alternative way to monitor PJI rates.Cite this article:

Identifiants

pubmed: 36047015
doi: 10.1302/0301-620X.104B9.BJJ-2022-0116.R1
pmc: PMC9948458
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1060-1066

Références

Bioinformatics. 2018 Nov 1;34(21):3711-3718
pubmed: 29757357
Bone Joint J. 2022 Feb;104-B(2):221-226
pubmed: 35094583
Clin Microbiol Infect. 2013 Feb;19(2):181-6
pubmed: 22264335
Arthroplast Today. 2017 Jun 20;3(2):137-140
pubmed: 28695187
Infect Control Hosp Epidemiol. 2021 Mar;42(3):325-330
pubmed: 32993826
Infect Control Hosp Epidemiol. 2016 Jun;37(6):699-703
pubmed: 27018968
J Orthop Surg (Hong Kong). 2008 Apr;16(1):58-65
pubmed: 18453662
Acta Orthop. 2015;86(4):491-7
pubmed: 25782042
J Arthroplasty. 2016 Jul;31(7):1422-6
pubmed: 26948176
Psychol Methods. 2009 Dec;14(4):323-48
pubmed: 19968396
Clin Microbiol Rev. 2014 Apr;27(2):302-45
pubmed: 24696437
Bone Jt Open. 2021 Jan 03;2(1):16-21
pubmed: 33537672
Pharmacoepidemiol Drug Saf. 2021 Sep;30(9):1184-1191
pubmed: 34170057
J Hosp Infect. 2015 Feb;89(2):82-9
pubmed: 25575769
J Am Acad Orthop Surg. 2020 Apr 15;28(8):e340-e348
pubmed: 31972719
Indian J Orthop. 2013 Jan;47(1):10-7
pubmed: 23531512
Acta Orthop. 2015 Jun;86(3):326-34
pubmed: 25637247
BMC Musculoskelet Disord. 2017 May 22;18(1):207
pubmed: 28532409
Lancet. 2016 Oct 8;388(10053):1545-1602
pubmed: 27733282
Arthritis Care Res (Hoboken). 2018 Jun;70(6):877-883
pubmed: 28898565
Acta Orthop. 2011 Dec;82(6):646-54
pubmed: 22066562
Acta Orthop. 2016 Aug;87(4):346-50
pubmed: 27348450
J Arthroplasty. 2014 Jul;29(7):1331
pubmed: 24768547
JB JS Open Access. 2018 Aug 15;3(3):e0007
pubmed: 30533590
BMJ Open. 2014 Sep 03;4(9):e005768
pubmed: 25186157
PLoS One. 2013 Aug 26;8(8):e71666
pubmed: 23990969
J Arthroplasty. 2022 Jan;37(1):126-131
pubmed: 34563434
BMC Musculoskelet Disord. 2014 Nov 19;15:384
pubmed: 25410189
J Arthroplasty. 2020 Feb;35(2):528-533
pubmed: 31615704
J Bone Jt Infect. 2018 Jun 8;3(3):108-117
pubmed: 30013891
Hip Int. 2015 Nov-Dec;25(6):568-73
pubmed: 26109151

Auteurs

Xingzhong Jin (X)

Centre for Big Data Research in Health, University of New South Wales, Sydney, Australia.
Sydney Musculoskeletal Health, Kolling Institute, The University of Sydney, Sydney, Australia.

Blanca Gallego Luxan (B)

Centre for Big Data Research in Health, University of New South Wales, Sydney, Australia.

Mark Hanly (M)

Centre for Big Data Research in Health, University of New South Wales, Sydney, Australia.

Nicole L Pratt (NL)

Quality Use of Medicines and Pharmacy Research Centre, Clinical and Health Sciences, University of South Australia, Adelaide, Australia.

Ian Harris (I)

Australian Orthopaedic Association National Joint Replacement Registry, South Australian Health and Medical Research Institute, Adelaide, Australia.
Ingham Institute for Applied Medical Research, South Western Sydney Clinical School, University of New South Wales, Sydney, Australia.

Richard de Steiger (R)

Australian Orthopaedic Association National Joint Replacement Registry, South Australian Health and Medical Research Institute, Adelaide, Australia.
Department of Surgery, Epworth HealthCare, University of Melbourne, Melbourne, Australia.

Stephen E Graves (SE)

Quality Use of Medicines and Pharmacy Research Centre, Clinical and Health Sciences, University of South Australia, Adelaide, Australia.
Australian Orthopaedic Association National Joint Replacement Registry, South Australian Health and Medical Research Institute, Adelaide, Australia.

Louisa Jorm (L)

Centre for Big Data Research in Health, University of New South Wales, Sydney, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH